Tocilizumab Use in a Chronic Hemodialysis Patient for the Management of COVID-19-Associated Pneumonia and Acute Respiratory Distress Syndrome

Table 1

Investigations.

	Day 1	Day 2	Day 3	Day 4	Day 5	Day 6	Day 7	Day 8	Day 9
BUN (mmol/L)	7.1	10.1	8.2	14.0	11.2	18.7	24.9	12.2	16.8
Creatinine (μmol/L)	624	820	604	789	674	926	1121	710	931
Sodium (mmol/L)	135	132	137	133	136	131	129	134	133
Potassium (mmol/L)	3.9	4.7	4.9	5.1	4.2	4.1	4.3	4.3	4.6
Chloride (mmol/L)	92	91	93	92	93	89	87	92	90
Calcium (mmol/L)	2.21	1.95	2.05	2.06	2.11	2.27	2.26	2.27	2.32
Phosphorous (mmol/L)		0.77	2.1	2.16	1.73	1.98	2.07	1.79	2.12
Total bilirubin (μmol/L)	3.6	4.3	5.0	3.6	3.7	4.4	3.6	4.0	3.3
Total protein/albumin (g/L)	69/38	68/36	66/34	64/32	64/34	67/35	66/33	67/35	65/35
AST (U/L)	87	111	125	69	115	133	61	46	34
ALT (U/L)	60	81	102	72	87	120	81	61	47
ALP (IU/L)	145	143	145	141	162	168	157	156	150
CRP (mg L)	163	193	242	136	97.5	77.9	57.9	45	30.2
IL 6 (ng/L)			7946	11024	10453	7360		2938
Pro calcitonin (mcg/L)		18.9	30.1	28.28
Ferritin (mcg/L)		6508	>8000	6656	5507	5152
Hemoglobin (g/L)	90	90	91	81	81	80	82	85	85
Hematocrit	0.27	0.27	0.28	0.25	0.25	0.24	0.24	0.26	0.26
WBC (×10^9L)	2.68	3.22	3.42	4.0	4.0	4.63	5.56	5.62	6.46
Neutrophil/lymphocyte (%)	84/12.9	68/27	62/26	70/16.8	66/16	65/18.6	66/18	63/20	60/20
Platelets (×10^9/L)	117	118	110	116	126	124	137	161	174
	Day 1	Day 2		Day 3	Day 4	Day 5	Day 6	Day 7
pH	7.4	7.49		7.40	7.42	7.43	7.43	7.44
PaCO2 (kPA)	4.7	4.8		5.43	4.43	5.48	4.72	4.29
PaO2 (kPA)	12.93	6.95		9.64	7.40	12.75	10.95	11.11
HCO3 (mmol/L)	25	27		24	21	27	23	22